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Neurodegenerative Disorder
Related to AIMP1/p43
Mutation Is Not a PMLDFigure 1. Magnetic Resonance Imaging of White Matter
Changes in Hypomyelinating Leukodystrophies
(A–D) In a normal brain (A), when themyelination is achieved, the
white matter signal is hyperintense relative to gray matter on
T1-weighted images and hypointense relative to gray matter on
T2-weighted and FLAIR images. In patients affected by hypomye-
linating leukodystrophies, T1 white matter signal is hypointense
relative to gray matter in severe form 0 related to proteolipid
potein 1 (PLP1 [MIM 300401]) mutation (patient B, 2 years old),
isointense in moderate form 3 related to PLP1 duplication (patient
C, 7 years old), and normally hyperintense in mild form 4 related
to gap junction protein gamma-2 (GJC2 [MIM 608803]) mutation
(patient D, 20 years old).9 In patients B and C, the white matter
signal on T2-weighted and FLAIR images appears hyperintense
relative to gray matter. In patient D, the white matter tends to
be isointense relative to gray matter on T2-weighted images,
except in posterior internal capsules, and is hyperintense in FLAIR
images.To the Editor: We read with great interest the article enti-
tled ‘‘Pelizaeus-Merzbacher-Like Disease Caused by AIMP1/
p43 Homozygous Mutation’’ by Feinstein et al, published
in the December 2010 issue of The Journal.1
Although this report highlights the potential deleterious
effects of one AIMP1/p43 (MIM 603605) mutation, we
think that the relationship to a Pelizaeus-Merzbacher-like
disease is erroneous and misleading.
The patients described by Feinstein et al. did not present
the core clinical and neuroradiological symptoms that
define a hypomyelinating leukodystrophy (HLD) corre-
sponding to either Pelizaeus-Merzbacher disease (PMD,
HLD1 [MIM 312080]) or Pelizaeus-Merzbacher-like disease
1 (PMLD1, HLD2 [MIM 608804]).2,3 In addition, those
patients presented additional features that did not conform
to diseases because of a primary central nervous system
(CNS) myelin formation defect.
Patients described in this single Israeli Bedouin family
presented with rapid neurologic deterioration, early micro-
cephaly, dysmorphia, spastic paraparesis, limb deformities,
and kyphoscoliosis. Although they presented horizontal or
rotatory nystagmus, which is often present in patients with
PMD or PMLD, the clinical symptoms presented by the
patients clearly differ from those observed in patients with
PMD or PMLD: microcephaly is never present, hypotonia
is prominent, spasticity and/or dystonia appear usually
after 2 years of age, and patients with PMD or PMLD do
not have dysmorphia, evenmild. In addition, themagnetic
resonance imaging (MRI) data provided in this report are
insufficient to state that the patients possibly have a severe
hypomyelinating leukodystrophy. T2-weighted and FLAIR
hypersignal of the white matter is observed in both
hypomyelinating and demyelinating leukodystrophies,
whereas both diseases have distinct T1-weighted signal of
the white matter.4,5 In demyelinating forms, white matter
T1 is always highly hypointense (relative to the cortex),
whereas it ranges from normally hyperintense in moderate
hypomyelination to mildly hypointense in severe hypo-
myelinating forms (Figure 1). Unlike what is mentioned
by Feinstein et al. in the legend of Figure 2D, the signal of
white matter on T1 sequence in the 14-month-old patient
appears normally hyperintense with respect to cerebral
cortex, suggesting an amount of myelin not compatible
with a severe form of PMD or PMLD (Figure 1B).
Even with stringent criteria, the deciphering of genetic
causes of CNS hypomyelinating diseases has remained
a challenge. The patients described by Feinstein et al.
present a complex phenotype, and the clinical and neuro-
imaging abnormalities suggest that they suffer from a
primitive severe axonal disease. It must be noticed that
the phenotype of patients with recessive mutations in392 The American Journal of Human Genetics 88, 391–395, March 1the gene encoding for heat shock 60 kDa protein 1
(HSPD1 [MIM 118190]), classified as hypomyelinating
leukodystrophy type 4 (HLD4 [MIM 612233]), also
suggests an early and severe axonal involvment.6 There-
fore, those phenotypes may rather correspond to infantile
forms of neuronal degenerative disorders. It must be
noticed that abnormal myelination is classically observed1, 2011
in such early-onset forms of neurodegenerative diseases.7
In this respect, it would have been interesting if the
authors had provided neurophysiological analyses, partic-
ularly on the peripheral nerve functions of their patients.
The clinical and MRI presentation of the AIMP1mutated
patients reported in this paper is in agreement with the
important role of AIMP1 in regulating neurofilament and
maintaining axon-cytoskeleton integrity, and not as a
primitive disorder of the myelination. Nevertheless, in
such a highly inbred population, we cannot rule out the
possibility of another mutated gene implicated in the
etiology of the complex phenotype.8
In conclusion, the genetician and neurologist cannot
consider AIMP1 as a candidate gene for PMLD mutations.
Patients with early severe neurodegenerative disorder
involving axonal functions and myelin development seem
presently more appropriate for AIMP1mutation screening.
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and Boepsflug-Tanguy et al.:
AIMP1/p43 Connatal PMLDTo the Editor: We have recently described a severe neuro-
logical phenotype with rapid progression over the first
months of life that is caused by a homozygous mutation
in AIMP1/p43.1 The study was approved by the Soroka
Medical Center Institutional Review Board. All patients
had severe failure to thrive with a concordant head circum-ference (not isolated microcephaly), severe global develop-
mental delay, and coarse face, yet no significant dysmor-
phism. Although the phenotype differs at some points
from the classical form of Pelizaeus-Merzbacher disease
(PMD), as suggested by Biancheri et al. and Boespflug-
Tanguy et al. in this issue of The Journal, it is extremely
similar to that of the severe (connatal) form of the
disease.2–4 The main features of the PMD clinical pheno-
type were apparent in our patients:1 nystagmus, hypotonia
with progressive spastic parapersis, and developmental
delay. Furthermore, dysarthria, wasting (dystrophy) of
the limbs, and kyphoscoliosis, found in our patients,can Journal of Human Genetics 88, 391–395, March 11, 2011 393
